DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Ambroxol

Ambroxol

  • More Than Expectorant: New Scientific Data on Ambroxol in the Context of the Treatment of Bronchopulmonary Diseases

    More Than Expectorant: New Scientific Data on Ambroxol in the Context of the Treatment of Bronchopulmonary Diseases

  • European Journal of Scientific Exploration Vol 3 №2 2020

    European Journal of Scientific Exploration Vol 3 №2 2020

  • Appendix on Tariff Elimination Schedule for Mercosur

    Appendix on Tariff Elimination Schedule for Mercosur

  • Research Article

    Research Article

  • Pharmaceutical Appendix to the Harmonized Tariff Schedule

    Pharmaceutical Appendix to the Harmonized Tariff Schedule

  • 1. Generic Names Levosalbutamol 0.25G Ambroxol 7.5Mg

    1. Generic Names Levosalbutamol 0.25G Ambroxol 7.5Mg

  • Trends in Prescription Medication Use Among Children and Adolescents— United States, 1999-2014

    Trends in Prescription Medication Use Among Children and Adolescents— United States, 1999-2014

  • Mucoactive Agents for Airway Mucus Hypersecretory Diseases

    Mucoactive Agents for Airway Mucus Hypersecretory Diseases

  • Ambroxol for the Treatment of Fibromyalgia: Science Or Fiction?

    Ambroxol for the Treatment of Fibromyalgia: Science Or Fiction?

  • Alphabetical Listing of ATC Drugs & Codes

    Alphabetical Listing of ATC Drugs & Codes

  • Class Update: Cough & Cold Preparations

    Class Update: Cough & Cold Preparations

  • 1. Composition Each 5Ml Contains Levosalbutamol 0.5Mg Ambroxol 15Mg Guaiphenesin 50 Mg

    1. Composition Each 5Ml Contains Levosalbutamol 0.5Mg Ambroxol 15Mg Guaiphenesin 50 Mg

  • Formulation Development of Stable Ambroxol Hydrochloride Syrup and Comparative Evaluation with Marketed Samples

    Formulation Development of Stable Ambroxol Hydrochloride Syrup and Comparative Evaluation with Marketed Samples

  • Estonian Statistics on Medicines 2013 1/44

    Estonian Statistics on Medicines 2013 1/44

  • Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections

    Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections

  • TMPRSS2 Inhibitors, Bromhexine, Aprotinin, Camostat and Nafamostat As Potential Treatments for COVID-19

    TMPRSS2 Inhibitors, Bromhexine, Aprotinin, Camostat and Nafamostat As Potential Treatments for COVID-19

  • WHO Drug Information Vol

    WHO Drug Information Vol

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

Top View
  • I (Acts Whose Publication Is Obligatory) COMMISSION
  • Chapter 6 |Management of Morbidity
  • Pdf, 0.99 MB AIPM-Remedium December 2014
  • Page 1 S C Routine Toxicology Library Drug 3,4
  • Methylnaltrexone Bromide
  • Development and Validation of Rp-Hplc and Hptlc Method of Analysis For
  • Development and Validation of UV Spectroscopic Method for Estimation of Guaifenesin in Tablet Dosage Form
  • Analysis of the Evidence of Efficacy and Safety of Over-The-Counter Cough Medications Registered in Brazil
  • Mucolytics, Expectorants, and Mucokinetic Medications
  • VI.2 Elements for a Public Summary
  • A Pharmaceutical Composition Comprising a Menthane Carboxylic Acid Amide
  • Benzonatate Has Local Anaesthetic Adverse Effects Acidosis
  • Descargo: a Fin De Garantizar El Efectivo Ejercicio Del Derecho De
  • ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
  • RMP Ambroxol Hydrochloride-Final 150915
  • Efficacy and Safety for the Combination of Levosalbutamol, Ambroxol and Guaifenesin for the Symptomatic Treatment of Productive Cough: Phase IV Clinical Trial
  • Effect of Drugs on Human Cough Reflex Sensitivity to Inhaled Capsaicin Peter V Dicpinigaitis1,2
  • Cystic Fibrosis Pulmonary Guidelines Chronic Medications for Maintenance of Lung Health


© 2024 Docslib.org    Feedback